• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tg Therapeuticscmn (NQ: TGTX )

    20.57 +0.59 (+2.93%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,991,231
    Open 20.21
    Bid (Size) 20.59 (10)
    Ask (Size) 20.80 (5)
    Prev. Close 19.98
    Today's Range 19.98 - 20.80
    52wk Range 6.460 - 23.12
    Shares Outstanding 150,977,564
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    $1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
    Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX). 
    Via Chartmill

    Performance

    YTD
    +20.69%
    +20.69%
    1 Month
    +15.99%
    +15.99%
    3 Month
    +52.67%
    +52.67%
    6 Month
    +30.16%
    +30.16%
    1 Year
    +3.76%
    +3.76%

    More News

    Read More
    "Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker
    Via The Motley Fool
    Nasdaq 100 Overbought? Here’s What History Says About The Current Rally
    Via Talk Markets
    The Most Shorted Stocks in June: Hold, Short, or Squeeze?
    Via MarketBeat
    (TGTX) - Analyzing TG Therapeutics's Short Interest
    Via Benzinga
    Peering Into TG Therapeutics's Recent Short Interest
    Via Benzinga
    (TGTX) - Analyzing TG Therapeutics's Short Interest
    Via Benzinga
    Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
    Via FinancialNewsMedia
    Exposures Product Safety
    Why TG Therapeutics Stock Was Rocketing Higher This Week
    Via The Motley Fool
    TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Earnings Preview For TG Therapeutics
    Via Benzinga
    How Is The Market Feeling About TG Therapeutics?
    Via Benzinga
    Looking Into TG Therapeutics's Recent Short Interest
    Via Benzinga
    Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
    From FN Media Group LLC
    Via GlobeNewswire
    TG Therapeutics stock just rallied 30%: what happened?
    Via Talk Markets
    Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today?
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
    Via Investor's Business Daily
    Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For February 28, 2024
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    7 Exciting Stocks Poised for Explosive Growth in Key Sectors
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.